| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
NKGN (NKGN) has 0 insiders with recent SEC Form 4 filings, including 19 buys and 0 sells. NKGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Cfic-2015 NV Family Investments, LLC | 10% Owner | Buy | 19,669,552 | $0.13 | $2,500,000.06 | +944.1% | |
| May 5, 2025 | Song Paul Y. | Chief Executive Officer | Buy | 20,849,725 | $0.13 | $2,650,000.05 | +12,184% | |
| Dec 7, 2023 | Song Paul Y. | Chief Executive Officer | Buy | 151 | $3.30 | $500.23 | - | |
| Dec 5, 2023 | Song Paul Y. | Chief Executive Officer | Buy | 268 | $3.17 | $849.95 | - | |
| Dec 4, 2023 | Graf James A | Interim CFO | Buy | 670 | $3.24 | $2,172.50 | +251.9% | |
| Nov 27, 2023 | Song Paul Y. | Chief Executive Officer | Buy | 244 | $2.88 | $700.60 | - | |
| Nov 22, 2023 | Song Paul Y. | Chief Executive Officer | Buy | 153 | $2.82 | $430.00 | - | |
| Nov 21, 2023 | Graf James A | Interim CFO | Buy | 23 | $2.93 | $67.30 | +230.0% | |
| Jun 1, 2021 | Graf James A | Chief Executive Officer | Buy | 5,000 | $9.90 | $49,500.00 | - | |
| May 27, 2021 | Graf James A | Chief Executive Officer | Buy | 500 | $9.92 | $4,959.60 | - |